Tucatinib and Dihydrocodeine: Interaction Details

Brand names
Tucatinib
Tukysa
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Dihydrocodeine

We don't have a separate drug information page for Dihydrocodeine. The FDA's drug directory lists it as part of Trezix (acetaminophen, caffeine and dihydrocodeine bitartrate). Have a question about Dihydrocodeine? Ask a pharmacist, free →

What Happens When You Take Tucatinib With Dihydrocodeine

What can happen when they are taken together (rated Major)

Increased dihydrocodeine exposure and an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Taking dihydrocodeine together with a can raise of the parent drug (codeine) and of its active (morphine), which may result in longer-lasting effects, respiratory depression among them. When the two agents must be given together, a lower dihydrocodeine dose should be considered, along with frequent monitoring for and respiratory depression. If the CYP3A4 inhibitor is later stopped, a higher dihydrocodeine dose may need to be considered, and the patient should be watched for signs of opioid withdrawal.12

The Tucatinib and Dihydrocodeine Interaction, Explained

Dihydrocodeine is an pain reliever. Tucatinib (Tukysa) is a cancer medicine that can slow down , a liver enzyme that helps break down dihydrocodeine. If that enzyme is slowed, more dihydrocodeine can stay in your body for longer. That could mean stronger or longer-lasting effects, like drowsiness and slowed breathing, which can be serious.

This concern is based on how the drugs work, not on reports from patients. Keep taking both exactly as prescribed. Your care team may adjust your dihydrocodeine dose and check on you more often. Tell your pharmacist or doctor if you feel unusually sleepy or have slow or shallow breathing.

Mechanism: Tucatinib is a . may reduce CYP3A4-mediated dihydrocodeine , raising exposure to the parent drug and prolonging effects, including and .

  • Direction: increased dihydrocodeine exposure (/).
  • Evidence: theoretical, no clinical interaction data cited. Onset unspecified. Severity on file: major.
  • Management: if is necessary, consider reducing the dihydrocodeine dose and monitor frequently for sedation and respiratory depression.
  • On discontinuing tucatinib: consider increasing the dihydrocodeine dose and monitor for opioid withdrawal signs.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Tucatinib and Dihydrocodeine Interact

The likely mechanism

of -mediated dihydrocodeine

In short: Tucatinib slows CYP3A4, an enzyme that breaks down dihydrocodeine, so dihydrocodeine can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Tucatinib and Dihydrocodeine Interaction

Your care team can manage this by tailoring your dose and monitoring.

  • Your dihydrocodeine dose may need to be adjusted and individualized by your care team while you take tucatinib.
  • Your team may monitor you more closely for sleepiness and slowed breathing.
  • If tucatinib is ever stopped, your dihydrocodeine dose may need another review, and your team may watch for withdrawal symptoms.

Keep taking both medicines as prescribed. Tell your pharmacist or prescriber about extra drowsiness, confusion, or slow or shallow breathing, and do not change any doses on your own.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Tucatinib or Dihydrocodeine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Tucatinib and Dihydrocodeine: Common Questions

How serious is the Tucatinib and Dihydrocodeine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Tucatinib and Dihydrocodeine interaction managed?

Your care team can manage this by tailoring your dose and monitoring. Your dihydrocodeine dose may need to be adjusted and individualized by your care team while you take tucatinib. Your team may monitor you more closely for sleepiness and slowed breathing. If tucatinib is ever stopped, your dihydrocodeine dose may need another review, and your team may watch for withdrawal symptoms. Keep taking b… Management is individual — always follow your own care team's guidance.

Does taking Tucatinib and Dihydrocodeine at different times of day help?

No. Taking them at different times of day does not prevent this one. Tucatinib slows , an enzyme that breaks down dihydrocodeine, so dihydrocodeine can build up in the body. That change lasts while tucatinib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Tucatinib and Dihydrocodeine Interaction

Ask in your own words about taking Tucatinib and Dihydrocodeine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: TREZIX(TM) oral capsules, acetaminophen caffeine dihydrocodeine bitartrate oral capsules. WraSer Pharmaceuticals (per DailyMed), Ridgeland, MS, 2016. DailyMed
  2. Product Information: SYNALGOS(R)-DC oral capsules, aspirin, caffeine, dihydrocodeine bitartrate oral capsules. Sun Pharmaceuticals Industries Inc (per FDA), Cranbury, NJ, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Tucatinib and Dihydrocodeine

Also serious with Dihydrocodeine

Also serious with Tucatinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Tucatinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.